Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 32 citing articles:

JAK inhibitor selectivity: new opportunities, better drugs?
Anniina Virtanen, Francesca Romana Spinelli, Jean Baptiste Telliez, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 10, pp. 649-665
Closed Access | Times Cited: 18
Infection risk with JAK inhibitors in dermatoses: a meta‐analysis
Patrick A. Ireland, Matthew J Verheyden, Nicholas Jansson, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 10
The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis
S. Veltkamp, Philip W. Voorneveld
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 608-608
Open Access | Times Cited: 1
A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis
Daniël Blockmans, Sara K. Penn, Arathi Setty, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 1
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
Miguel Mansilla‐Polo, D. Morgado‐Carrasco
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 1983-2038
Open Access | Times Cited: 8
Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination
Minako Yamaoka‐Tojo, Taiki Tojo
Vaccines (2024) Vol. 12, Iss. 3, pp. 252-252
Open Access | Times Cited: 5
Where are we now in biologic drugs for myositis?
Ana Neves, Luísa Viveiros, Veronica Venturelli, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 11, pp. 2938-2947
Open Access | Times Cited: 4
Chinese herbal medicines and its active ingredient wogonin can improve immune inflammation in psoriatic arthritis
Xianheng Zhang, Jian Liu, Xiang Ding, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113984-113984
Closed Access
Herpes zoster infection in adults with rheumatic diseases in Colombia: A real world-data analysis
Néstor Correa-González, Daniel G. Fernández‐Ávila, Diana Carolina Sandoval, et al.
The Egyptian Rheumatologist (2025) Vol. 47, Iss. 3, pp. 143-147
Closed Access
An update ont the safety of biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
A. Zimmer, Gerd Horneff
Expert Opinion on Drug Safety (2025)
Closed Access
Observation of the efficacy of upadacitinib as salvage therapy for refractory pediatric inflammatory bowel disease
Tian-Lu Mei, Yi Wang, Chunna Zhao, et al.
Journal of Pediatric Gastroenterology and Nutrition (2025)
Closed Access
Drug-induced herpes zoster: a pharmacovigilance analysis of FDA adverse event reports from 2004 to 2024
Jiali Xia, Jing Zhang, Zhu Hongyu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Exploring Novel Therapies for Idiopathic Inflammatory Myopathies and Examining Future Perspectives
Luciana Molinero, Joan Padrosa, Iago Pinal-Fernández, et al.
Current Treatment Options in Rheumatology (2025) Vol. 11, Iss. 1
Closed Access
Update: Medikamentöse Therapie bei Colitis ulcerosa
Elena Sonnenberg, Britta Siegmund, Carl Weidinger
DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 08, pp. 412-418
Closed Access
Off-label use of recombinant adjuvanted Herpes Zoster vaccine in a 10-year-old high-risk patient affected by epidermolysis bullosa: A case report
Claudia Palmieri, Chiara Noviello, Lorenza Moscara, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases
Giulia Ciccarese, Francesco Drago, Astrid Herzum, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 4
Open Access | Times Cited: 3
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine
Ryuhei Ishihara, Ryu Watanabe, Mayu Shiomi, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 739-739
Open Access | Times Cited: 3
Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study
Po‐Ku Chen, Shih‐Hsin Chang, Yi‐Ming Chen, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 8, pp. 2503-2511
Closed Access | Times Cited: 3
Immunogenicity to Herpes Zoster recombinant subunit vaccine in immune-mediated rheumatic patients under treatment with JAK inhibitors
C. Sieiro Santos, Juan Garcia Herrero, José Ordás Martínez, et al.
Lara D. Veeken (2024)
Closed Access | Times Cited: 3
Upadacitinib is associated with clinical response and steroid‐free remission for children and adolescents with inflammatory bowel disease
Joseph Runde, Kelsey Ryan, Joseph B. Hirst, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024)
Closed Access | Times Cited: 2
Yang and Ying of ruxolitinib administration for macrophage activation syndrome complicated by systemic juvenile idiopathic arthritis
Hitoshi Irabu, Shuya Kaneko, Futaba Miyaoka, et al.
Lara D. Veeken (2024)
Closed Access | Times Cited: 2
Kaposi sarcoma in a MSM patient without HIV who was treated with upadacitinib for ulcerative colitis
Jacob T. Tribble, M. L. Johnson, Yeanna Moon, et al.
JAAD Case Reports (2024) Vol. 50, pp. 119-122
Open Access | Times Cited: 1
Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis
Konstantinos Ouranos, Diana Avila, Evangelia K. Mylona, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0306548-e0306548
Open Access | Times Cited: 1
The relationship between Zoster serology, vaccination uptake and infection rates: a single centre cross sectional study
Saad Ahmed, Martin Lauran, Adaeze Ugwoke, et al.
Rheumatology Advances in Practice (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 1
Adverse reactions to Janus kinase inhibitors: Study of their incidence and predictive factors in patients with rheumatoid arthritis
Cristina Martinez-Molina, Josep M. Guardiola, Jesús Ruiz Ramos, et al.
Medicina Clínica (English Edition) (2024)
Closed Access
Page 1 - Next Page

Scroll to top